Skip to main content
. 2019 Mar 27;13(3):e0007216. doi: 10.1371/journal.pntd.0007216

Table 2. Delay between baseline screening and time of onset of disease for 17 VL casesin relation to their initial DAT, rK39 and qPCR status.

ELISA titer DAT titer qPCR Delay between baseline and appearance of VL
(months)
HIGH HIGH POSITIVE 1
HIGH HIGH NEGATIVE 2
HIGH HIGH POSITIVE 3
HIGH HIGH POSITIVE 3
HIGH HIGH POSITIVE 3
HIGH HIGH POSITIVE 4
NEGATIVE NEGATIVE NEGATIVE 6
NEGATIVE NEGATIVE NEGATIVE 6
MODERATE HIGH NEGATIVE 6
NEGATIVE MODERATE POSITIVE 7
NEGATIVE NEGATIVE NEGATIVE 8
HIGH HIGH NEGATIVE 9
NEGATIVE NEGATIVE NEGATIVE 18
NEGATIVE NEGATIVE NEGATIVE 27
NEGATIVE NEGATIVE NEGATIVE 32
NEGATIVE NEGATIVE NEGATIVE 43
NEGATIVE NEGATIVE NEGATIVE 51